The global antibody therapeutics market is witnessing a period of substantial growth. This trend can be attributed to several factors, such as the increasing prevalence of chronic diseases, advancements in biotechnology, and growing acceptance of biologics. The market is estimated to increase at a growth rate of Z% during the forecast period, drive